Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc."
Results 121 - 140
of 289
Sorted by Relevance
|
Sort by Date
21 Oct 2017, 9:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), General Electric Co. v. [read post]
31 Mar 2016, 6:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U. [read post]
20 Aug 2012, 7:04 am
Merrell Dow Pharmaceuticals, Inc.? [read post]
31 Mar 2016, 6:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U. [read post]
27 May 2014, 10:59 am
Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579, 589, 113 S.Ct. 2786, 125 L.Ed.2d 469 [1993]).Admissibility Ruling:U.S. [read post]
28 Jun 2016, 6:00 am
Merrell Dow Pharmaceuticals. [read post]
24 May 2018, 5:51 am
Merrel Dow Pharmaceuticals. [read post]
25 Jan 2011, 10:06 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993). [read post]
21 Oct 2018, 10:29 am
Merrell Dow Pharmaceuticals, Inc., U.S. [read post]
7 Jul 2014, 8:10 am
Merrell Dow Pharmaceuticals, Inc. (509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 [1993]) by resolving doubts in favor of keeping the testimony out and relying upon its own assessment of the correctness of the expert opinions, the panel said. [read post]
11 Mar 2011, 2:03 pm
In 1993 in Daubert v. [read post]
18 Sep 2019, 5:00 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
5 Apr 2010, 1:01 pm
Dow Merrell Pharmaceuticals, Inc., which prohibit the use of inaccurate, nonspecific tests and/or conclusory reports because they do not prove the presence of marijuana in a seized substance. [read post]
29 Jan 2022, 6:24 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993), Fed.Rules, Evid.Rules 104(a), 702. [read post]
22 Sep 2014, 12:19 pm
Case:Honeywell International, Inc. v. [read post]
15 May 2014, 9:36 am
Breg Inc., 613 F.3d 1329, 1342 (11th Cir. 2010); see also Norris v. [read post]
17 Jan 2014, 8:27 pm
Merrell Dow Pharmaceuticals, Inc., the United States Supreme Court held for the first time that, to be admissible, scientific evidence must be both scientifically valid and properly applicable to the facts at issue in the case. [read post]
17 Mar 2014, 6:57 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
22 Feb 2011, 7:27 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in analyzing the expert presentations relating to the Rule 23 requirements, Plaintiffs contend that the Ninth Circuit found this to be no abuse of discretion, and that it did not matter because the district court judge was "guided by Daubert," concluded that the expert opinions were "based on valid principles," and were "sufficiently probative" of the Rule 23… [read post]
22 Feb 2011, 7:27 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in analyzing the expert presentations relating to the Rule 23 requirements, Plaintiffs contend that the Ninth Circuit found this to be no abuse of discretion, and that it did not matter because the district court judge was "guided by Daubert," concluded that the expert opinions were "based on valid principles," and were "sufficiently probative" of the Rule 23 requirements. [read post]
